Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Onkologie
|
July 7, 2001
Therapy-Related Leukemia following High-Dose Chemotherapy: Compensating for the Benefit?
C. Kollmannsberger, C. Bokemeyer
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2015
Agenda science: turning nothing into something: a response to the editorial by Oldenburg et al. and its featured article by Vidal et al
C Kollmannsberger, C Nichols
Current Oncology (Toronto, Ont.)
|
May 30, 2009
State-of-the-art treatment of metastatic renal cell carcinoma
D Y C Heng, C Kollmannsberger
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2006
Treatment of germ cell tumors--update 2006
C Kollmannsberger, F Honecker, C Bokemeyer
Expert Opinion on Pharmacotherapy
|
August 20, 2008
Pharmacotherapy of relapsed metastatic testicular cancer
C Kollmannsberger, F Honecker, C Bokemeyer
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 22, 2017
Novel treatment options for refractory Germ Cell Tumours: back to the bench!
C Kollmannsberger, L Nappi, C Nichols
Cancer Treatment Reviews
|
September 5, 1998
Chemotherapy in advanced pancreatic adenocarcinoma
C Kollmannsberger, H D Peters, U Fink
Praxis
|
November 9, 2000
[Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas]
C Bokemeyer, C Kollmannsberger, H Oettle, et al.
Critical Reviews in Oncology/Hematology
|
September 10, 2003
Current aspects of high-dose chemotherapy in germ-cell tumors
O Rick, C Kollmannsberger, J Beyer, et al.
Der Urologe. Ausg. A
|
January 15, 1999
[Late toxicity after chemotherapy of malignant testicular tumors]
A Jakob, C Kollmannsberger, L Kanz, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Onkologie
|
July 7, 2001
Therapy-Related Leukemia following High-Dose Chemotherapy: Compensating for the Benefit?
C. Kollmannsberger, C. Bokemeyer
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2015
Agenda science: turning nothing into something: a response to the editorial by Oldenburg et al. and its featured article by Vidal et al
C Kollmannsberger, C Nichols
Current Oncology (Toronto, Ont.)
|
May 30, 2009
State-of-the-art treatment of metastatic renal cell carcinoma
D Y C Heng, C Kollmannsberger
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2006
Treatment of germ cell tumors--update 2006
C Kollmannsberger, F Honecker, C Bokemeyer
Expert Opinion on Pharmacotherapy
|
August 20, 2008
Pharmacotherapy of relapsed metastatic testicular cancer
C Kollmannsberger, F Honecker, C Bokemeyer
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 22, 2017
Novel treatment options for refractory Germ Cell Tumours: back to the bench!
C Kollmannsberger, L Nappi, C Nichols
Cancer Treatment Reviews
|
September 5, 1998
Chemotherapy in advanced pancreatic adenocarcinoma
C Kollmannsberger, H D Peters, U Fink
Praxis
|
November 9, 2000
[Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas]
C Bokemeyer, C Kollmannsberger, H Oettle, et al.
Critical Reviews in Oncology/Hematology
|
September 10, 2003
Current aspects of high-dose chemotherapy in germ-cell tumors
O Rick, C Kollmannsberger, J Beyer, et al.
Der Urologe. Ausg. A
|
January 15, 1999
[Late toxicity after chemotherapy of malignant testicular tumors]
A Jakob, C Kollmannsberger, L Kanz, et al.
Page
of 9